Patent 7820809 was granted and assigned to Dharmacon, Inc. on October, 2010 by the United States Patent and Trademark Office.
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.